Modi Govt Plans Drug Supply Chain Overhaul: What Changes For Medicine Makers, Sellers And Patients?

The Centre has proposed stricter regulations to strengthen India's pharmaceutical supply chain and tackle antimicrobial resistance (AMR). Under the draft amendments, fresh manufacturing licences for antibiotics and other antimicrobials will require prior approval from the Central Licensing Authority. The government has also proposed separate licences for bulk drug wholesalers, including those handling Active Pharmaceutical Ingredients (APIs), to improve tracking and prevent diversion. In another major move, Good Storage and Distribution Practices (GSDP) may be brought under the Drugs Rules, 1945, covering medicine procurement, storage, transportation and distribution. The proposals aim to ensure medicine quality at every stage, from manufacturing to delivery. The draft amendments are open to public and stakeholder comments and are not yet in force.
Read more